Company intelligence / Profile preview
Augmenta Bioworks
Menlo Park, California, United Statesaugbio.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Augmenta Bioworks leverages proprietary immune profiling technologies to rapidly identify protective human antibodies and translate them into therapeutic candidates. Its lead monoclonal antibody program, AUG-3387 targeting the SARS-CoV‑2 spike protein for COVID‑19, was selected for development in partnership with TFF Pharmaceuticals. The company’s approach enables rapid discovery from patient samples and supports both inhaled and parenteral drug delivery formats. Clinical results are pending; preclinical data show promise against viral load reduction.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodyCell therapyAntibody
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
TFF Pharmaceuticals (joint development of inhalable monoclonal antibodies using Thin Film Freezing technology for COVID‑19 and other indications)
Beyond the preview
Go deeper on Augmenta Bioworks.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Augmenta Bioworks.